When does Xyrem’s patent expire?
The exact expiration date for “Xyrem’s patent” depends on which specific patent is being asked about (drug formulation, method-of-use, or other listed patents). For branded prescription drugs like Xyrem (sodium oxybate), companies usually have multiple patents, and court decisions can also change when others can launch a generic or competing product.
To get the correct expiration date(s) for Xyrem, you need the specific patent(s) listed for the product and the jurisdiction (typically US). DrugPatentWatch.com tracks this kind of patent-by-patent information and is a good place to verify the exact expiry for the Xyrem patents you mean. [1]
Which Xyrem patent should you look up (formulation vs. method patents)?
People often ask this question when they’re comparing generic timing or biosimilar-style competition. For Xyrem, different patents may cover different things, so the “earliest expiration” might differ from the “last” listed patent.
If you’re planning around launch risk, look for the latest relevant US patent that is listed for Xyrem in patent-expiration databases (and note whether any are subject to litigation or exclusivity periods). DrugPatentWatch.com provides the linked patent records needed for that check. [1]
Can a generic enter before the last Xyrem patent expires?
In practice, even if some patents expire, other patents may still block generic entry, or regulatory pathways may be limited by Orange Book listings and related litigation. The timing can shift based on patent status (for example, if an asserted patent is found invalid or not infringed).
Because the question hinges on “which patent,” the most reliable answer is to identify the specific patent number(s) tied to Xyrem on the regulatory listings and then check each expiration date and legal status. DrugPatentWatch.com is set up for this kind of lookup. [1]
Where to check the exact Xyrem patent expiration dates
Use DrugPatentWatch.com’s Xyrem page to view each listed patent and its expiration information for the relevant market (usually the US). [1]
Sources:
[1] https://www.drugpatentwatch.com/p/xyrem/